Intrinsic Value

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Buzzing stocks: BSE, Happiest Minds, HeidelbergCement, Piramal Enterprises, BoB, Om Infra, Shilpa Medicare, PTC Industries, Maharashtra Seamless, Mrs Bectors Food, Orchid Pharma, KNR Constructions, Jagsonpal Pharma

Stocks that will see action on July 18, 2022

The MD said the firm has crossed the revival phase and evidenced various positive developments.

Orchid Pharma all set to launch new products | The Financial Express

Orchid Pharma reports consolidated net loss of Rs 6.59 crore in the March 2022 quarter

Catch all live updates on share prices, index moves, corporate announcements and more from the Sensex and Nifty, today.

Share Market Live: Sensex, Nifty Rise; Orchid Pharma Adds 50% In Seven Days

Adani Wilmar, Coal India, Dish Tv, Eicher Motors, Grasim, Medplus Health, MTNL, Nagarjuna Fertilizers, PC Jeweller, Railtel, Rajesh Exports, Spandana Sphoorty and SpiceJet to announce results today.

Stocks to Watch: Apollo Hospitals, Nazara, DB Realty, Orchid Pharma, auto

BPCL, IOC, ONGC, ICICI Bank और Orchid Pharma जैसे कई दिग्गज Stocks पर खरीदारी से पहले Experts से लें सलाह, जानें कौन से Stocks में दिखेगा दवाब और कौन से Stocks में दिखेगी शानदार तेजी, देखे वीडियो

#CNBCAwaazLive #AajKaTajaKhabar #BusinessNewsLive #StockMarketLive #ShareMarketLive


Share Market से जुड़ी हर छोटी या बड़ी खबर, चाहे हो Nifty में आए नए हाई या फिर, हो आपके के लिए स्टॉक्स पर राय, बिजनेस न्यूज हो या पॉलिटिकल न्यूज, कोरोनावायरस की न्यूज हो या फिर इलेक्शन, देखें CNBC Awaaz और रहे हर खबर से updated.


CNBC Awaaz is India’s number one business channel and an undisputed leader in business news and information for the last ten years. Our channel aims to educate, inform and inspire consumers to go beyond limitations, with practical tips on personal finance, investing, technology, consumer goods and capital markets. Policymakers and business owners alike have grown to trust CNBC Awaaz as the most reliable source with its eye on India’s business climate. Our programming gives consumers a platform to make decisions with confidence.

Subscribe to the CNBC Awaaz YouTube channel here: https://tinyurl.com/y5rsvesk

Follow CNBC Awaaz on Twitter: https://twitter.com/CNBC_Awaaz
Like us on our CNBC Awaaz Facebook page: https://www.facebook.com/cnbcawaaz
Website: https://bit.ly/3230WJW

BPCL, IOC, ONGC, ICICI Bank, Orchid Pharma जैसे दिग्गज Stocks पर Buy करें या Sell? | CNBC Awaaz

Board of Orchid Pharma approves draft scheme of amalgamation and arrangement

Buzzing stocks are Orchid Pharma, Swan Energy, Engineers India, HAL, Car Trade, RITES, BEML, Bharat Electronics, HPCL, Persistent Systems, Warren Tea, KPI Global, Kings Infra

Stocks that will see action today (December 17)

14,803 Global Depository Receipts of the company have been delisted from the Luxembourg Stock Exchange with effect from November 15, 2021.

Orchid Pharma terminates deposit agreements with Citibank, N.A and delists GDR’s; Stock dips 2.5%

The rating on long-term bank facilities of the company has been revised to CARE BBB -; Stable.

CARE revises credit rating for bank facilities of Orchid Pharma; Stock ends 2% lower

The total number of GDRs has reduced from 32,26,688 constituting 3.63% of the total paid-up share capital to 14,803 GDRs constituting 0.04 % of the paid-up share capital of the company.

Orchid Pharma terminates deposit agreements to delist GDRs from international exchanges; Stock under pressure

Orchid Pharma Limited is an India-based pharmaceutical company. The Company is involved in the development, manufacture and marketing of diverse bulk actives, formulations and nutraceuticals. It has a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardiovascular segment (CVS), nutraceuticals and other oral and sterile products. Its pharmaceutical solutions include active pharmaceutical ingredients (APIs) and finished dosage forms. It offers APIs, including Cephalosporins-Orals, Cephalosporins-Injectables, Veterinary Products and Non-Antibodies. Its formulations include Cefixime Capsules, Acarbose Tablets, Acarbose Tablets, Clozapime Tablets, Clopidogrel Tablets, Desloratadine Tablets and Cefoperazone and Sulbactam for Injection, among others. Its subsidiaries include Orchid Europe Limited, Orchid Pharmaceuticals Inc., Bexel Pharmaceuticals Inc., and Diakron Pharmaceuticals, Inc., among others.

Orchid Pharma Ltd

Orchid Pharma Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Stocks that will see action on July 18, 2022

Orchid Pharma all set to launch new products | The Financial Express

Orchid Pharma reports consolidated net loss of Rs 6.59 crore in the March 2022 quarter

Share Market Live: Sensex, Nifty Rise; Orchid Pharma Adds 50% In Seven Days

Stocks to Watch: Apollo Hospitals, Nazara, DB Realty, Orchid Pharma, auto

News Video

BPCL, IOC, ONGC, ICICI Bank, Orchid Pharma जैसे दिग्गज Stocks पर Buy करें या Sell? | CNBC Awaaz

Board of Orchid Pharma approves draft scheme of amalgamation and arrangement

Orchid Pharma Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Stocks that will see action on July 18, 2022

Orchid Pharma all set to launch new products | The Financial Express

Orchid Pharma reports consolidated net loss of Rs 6.59 crore in the March 2022 quarter

Share Market Live: Sensex, Nifty Rise; Orchid Pharma Adds 50% In Seven Days

Stocks to Watch: Apollo Hospitals, Nazara, DB Realty, Orchid Pharma, auto

News Video

BPCL, IOC, ONGC, ICICI Bank, Orchid Pharma जैसे दिग्गज Stocks पर Buy करें या Sell? | CNBC Awaaz

Board of Orchid Pharma approves draft scheme of amalgamation and arrangement

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock